Affymetrix revenue was $359.79 m in FY, 2015 which is a 3.1% year over year increase from the previous period.

## Founding Date | 1994 |

Affymetrix is a subsidiary of Thermo Fisher Scientific

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|

## Revenue | 267.5m | 295.6m | 330.4m | 349.0m | 359.8m |

| 6% | 3% | |||

## Cost of goods sold | 97.8m | 116.3m | 134.0m | 117.5m | 110.8m |

## Gross profit | 169.7m | 179.4m | 196.4m | 231.5m | 249.0m |

| 63% | 61% | 59% | 66% | 69% |

## Sales and marketing expense | 2.0m | ||||

## R&D expense | 63.6m | 57.9m | 47.7m | 50.2m | 52.9m |

## General and administrative expense | 109.6m | 142.9m | 141.4m | 148.4m | 149.6m |

## Operating expense total | 186.3m | 218.5m | 209.0m | 229.4m | 232.3m |

## EBIT | (16.6m) | (39.1m) | (12.6m) | 2.1m | 16.7m |

| (6%) | (13%) | (4%) | 1% | 5% |

## Interest expense | 3.8m | 7.2m | 12.7m | 6.4m | 6.6m |

## Pre tax profit | (26.8m) | (46.5m) | (15.2m) | (3.6m) | 10.8m |

## Income tax expense | 1.4m | (35.9m) | 1.2m | 236.0k | 733.0k |

## Net Income | (28.2m) | (10.7m) | (16.3m) | (3.8m) | 10.1m |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|

## Cash | 201.9m | 25.7m | 57.1m | 79.9m | 88.8m |

## Accounts Receivable | 44.0m | 53.9m | 50.9m | 46.9m | 59.0m |

## Prepaid Expenses | 7.8m | 10.1m | 8.9m | 9.2m | 7.7m |

## Inventories | 42.9m | 72.7m | 58.1m | 50.7m | 54.1m |

## Current Assets | 314.6m | 172.8m | 175.7m | 190.5m | 259.5m |

## PP&E | 30.6m | 28.7m | 18.7m | 18.1m | 21.0m |

## Goodwill | 159.7m | 161.6m | 156.2m | 154.5m | |

## Total Assets | 438.0m | 544.3m | 504.5m | 486.5m | 546.9m |

## Accounts Payable | 44.8m | 13.7m | 9.6m | 10.8m | 10.9m |

## Short-term debt | 12.7m | 4.0m | 4.0m | ||

## Current Liabilities | 54.6m | 75.4m | 76.9m | 66.3m | 68.6m |

## Long-term debt | 95.5m | 73.3m | 105.0m | 105.0m | 105.0m |

## Total Debt | 95.5m | 86.0m | 109.0m | ||

## Common Stock | 704.0k | 710.0k | 723.0k | 743.0k | 805.0k |

## Additional Paid-in Capital | 750.3m | 759.5m | 768.1m | 781.7m | 847.3m |

## Retained Earnings | (478.7m) | (489.4m) | (505.7m) | (509.6m) | (499.4m) |

## Total Equity | 274.8m | 277.2m | 271.5m | 272.3m | 339.3m |

## Financial Leverage | 1.6 x | 2 x | 1.9 x | 1.8 x | 1.6 x |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|

## Net Income | (28.2m) | (10.7m) | (16.3m) | (3.8m) | 10.1m |

## Depreciation and Amortization | 32.3m | 36.1m | 39.0m | 30.7m | 21.8m |

## Accounts Receivable | 8.3m | (514.0k) | 2.3m | 2.8m | (12.0m) |

## Inventories | 6.5m | 12.0k | 2.5m | 603.0k | (1.1m) |

## Accounts Payable | (448.0k) | (21.7m) | (816.0k) | 8.8m | 2.4m |

## Cash From Operating Activities | 39.3m | 3.7m | 53.6m | 43.5m | 36.5m |

## Purchases of PP&E | (5.8m) | (8.2m) | (4.8m) | (7.9m) | (10.5m) |

## Cash From Investing Activities | 127.6m | (258.9m) | 15.7m | (4.7m) | (73.2m) |

## Cash From Financing Activities | (486.0k) | 78.5m | (37.9m) | (15.3m) | 46.1m |

## Net Change in Cash | 166.5m | (176.3m) | 31.5m | 22.8m | 8.8m |

## Interest Paid | 3.3m | (7.0m) | 12.5m | 5.4m | 4.8m |

## Income Taxes Paid | 633.0k | 3.9m | (2.2m) |

USD | Q2, 2011 |
---|---|

## Financial Leverage | 1.5 x |